SMMT · Summit Therapeutics Inc.
$12.80
+0.25 (+1.99%)
At close · Jul 29
Market Cap
$10.01B
Shares
797.75M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding SMMT
191 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | — | 5,948,323 | $112,780,204 | 1.04% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 4,866,448 | $92,267,854 | 1.24% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 3,755,154 | $71,197,720 | 0.00% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,680,105 | $50,814,791 | 0.03% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 2,652,737 | $46,529,007 | 0.05% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,718,526 | $32,583,253 | 0.04% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP VALUE INDEX FUND | — | 1,707,539 | $32,374,939 | 0.05% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 1,067,669 | $18,726,914 | 0.36% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | — | 799,477 | $15,158,084 | 0.19% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap Growth ETF | — | 782,939 | $14,844,523 | 0.08% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 800,000 | $14,032,000 | 0.24% | Long | 2026-05-31 | |
| Fidelity Extended Market Index Fund | — | 797,519 | $13,988,483 | 0.03% | Long | 2026-05-31 | |
| Fidelity Growth Company K6 Fund | — | 778,918 | $13,662,222 | 0.05% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | — | 659,283 | $11,563,824 | 0.05% | Long | 2026-05-31 | |
| Fidelity Mid Cap Index Fund | — | 432,667 | $9,285,034 | 0.02% | Long | 2026-04-30 | |
| Fidelity Contrafund | — | 489,110 | $9,273,526 | 0.01% | Long | 2026-03-31 | |
| iShares Russell 1000 Growth ETF | — | 480,979 | $9,119,362 | 0.01% | Long | 2026-03-31 | |
| Fidelity Advisor Health Care Fund | — | 400,000 | $8,584,000 | 0.30% | Long | 2026-04-30 | |
| iShares Russell Mid-Cap ETF | — | 449,261 | $8,517,989 | 0.02% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 471,305 | $8,266,690 | 0.03% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 462,390 | $8,110,321 | 0.04% | Long | 2026-05-31 | |
| abrdn Healthcare Investors | HQH | 427,133 | $8,098,442 | 0.71% | Long | 2026-03-31 | |
| Schwab U.S. Mid-Cap ETF | — | 416,668 | $7,308,357 | 0.05% | Long | 2026-05-31 | |
| Invesco NASDAQ Next Gen 100 ETF | — | 400,245 | $7,020,297 | 0.63% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 362,900 | $6,880,584 | 1.04% | Long | 2026-03-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 278,847 | $5,984,057 | 1.15% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 298,393 | $5,233,813 | 0.00% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 276,987 | $4,858,352 | 0.08% | Long | 2026-05-29 | |
| abrdn Life Sciences Investors | HQL | 238,231 | $4,516,860 | 0.81% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 234,470 | $4,112,604 | 0.00% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 210,850 | $3,997,716 | 0.01% | Long | 2026-03-31 | |
| Fidelity Large Cap Growth Index Fund | — | 166,159 | $3,565,772 | 0.01% | Long | 2026-04-30 | |
| Goldman Sachs Equal Weight U.S. Large Cap Equity ETF | — | 196,432 | $3,445,417 | 0.19% | Long | 2026-05-31 | |
| VIP Health Care Portfolio | — | 180,000 | $3,412,800 | 0.34% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND | — | 193,100 | $3,386,974 | 0.01% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 191,092 | $3,351,754 | 0.03% | Long | 2026-05-31 | |
| Schwab U.S. Large-Cap ETF | — | 175,386 | $3,076,270 | 0.00% | Long | 2026-05-31 | |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | — | 160,550 | $3,044,028 | 0.07% | Long | 2026-03-31 | |
| Fidelity Mid Cap Growth Index Fund | — | 142,674 | $2,705,099 | 0.08% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 131,177 | $2,487,116 | 1.09% | Long | 2026-03-31 | |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND | — | 129,855 | $2,462,051 | 0.01% | Long | 2026-03-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 116,250 | $2,204,100 | 0.22% | Long | 2026-03-31 | |
| Nuveen Equity Index Fund | — | 102,422 | $2,197,976 | 0.00% | Long | 2026-04-30 | |
| Tema Oncology ETF | — | 121,097 | $2,124,041 | 1.21% | Long | 2026-05-31 | |
| Schwab Total Stock Market Index Fund | — | 90,467 | $1,941,422 | 0.00% | Long | 2026-04-30 | |
| VANGUARD TOTAL WORLD STOCK INDEX FUND | — | 89,491 | $1,920,477 | 0.00% | Long | 2026-04-30 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 86,301 | $1,852,019 | 1.01% | Long | 2026-04-30 | |
| Fidelity Contrafund K6 | — | 97,340 | $1,845,566 | 0.01% | Long | 2026-03-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 90,599 | $1,717,757 | 1.08% | Long | 2026-03-31 | |
| Fidelity ZERO Total Market Index Fund | — | 79,596 | $1,708,130 | 0.00% | Long | 2026-04-30 |
Showing 1–50 of 191 positions
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
35 filings
35 filers
Visit website
Investor relations